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ABSTRACT
Protein–RNA cross-linking combined with mass spectrometry is a powerful tool to elucidate hitherto noncharacterized protein–
RNA contacts in ribonucleoprotein particles, as, for example, within spliceosomes. Here, we describe an improved methodology
for the sequence analysis of purified peptide–RNA oligonucleotide cross-links that is based solely on MALDI-ToF mass spectrome-
try. The utility of this methodology is demonstrated on cross-links isolated from UV-irradiated spliceosomal particles; these were
(1) [15.5K–61K–U4atac] small nuclear ribonucleoprotein (snRNP) particles prepared by reconstitution in vitro, and (2) U1 snRNP
particles purified from HeLa cells. We show that the use of 20,40,60-trihydroxyacetophenone (THAP) as MALDI matrix allows
analysis of cross-linked peptide–RNA oligonucleotides in the reflectron mode at high resolution, enabling sufficient accuracy to
assign unambiguously cross-linked RNA sequences. Most important, post-source decay (PSD) analysis under these conditions was
successfully applied to obtain sequence information about the cross-linked peptide and RNA moieties within a single spectrum,
including the identification of the actual cross-linking site. Thus, in U4atac snRNA we identified His270 in the spliceosomal U4/U6
snRNP-specific protein 61K (hPrp31p) cross-linked to U44; in the U1 snRNP we show that Leu175 of the U1 snRNP-specific 70K
protein is cross-linked to U30 of U1 snRNA. This type of analysis is applicable to any type of RNP complex and may be expected to
pave the way for the further analysis of protein–RNA complexes in much lower abundance and/or of cross-links that are obtained
in low yield.
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INTRODUCTION
RNAmoleculesplay a fundamental role in cellular processes such
as gene expression (transcription and pre-mRNA processing),
post-transcriptional control (mRNA stability), RNA export,
ribosomal RNA (rRNA) maturation, translation, and transla-
tional control. RNA molecules that are involved in these pro-
cesses are rarely active in the absence of proteins, but are found as
components of stable ribonucleoprotein (RNP) particles.
Since protein–RNA interactions lie at the structural and
functional heart of the RNP particles, much attention is
currently being devoted to the question of protein and RNA
tertiary structures and the quaternary arrangement of the
individual macromolecules in the RNP particles. Together
with the fact that the number of isolated RNP (sub-) com-
plexes from viruses, eubacteria, archaea, and eukaryotes is
steadily increasing, one important challenge in this field is
the development of a highly sensitive and generally applica-
ble method that allows the identification of hitherto
uncharacterized RNA binding proteins and the localization
of their regions of interactions.
Cross-linking is the method of choice to link a protein
covalently to its cognate RNA in RNP particles, and, most
importantly, it is so far the only technique that is capable of
proving that a certain protein is indeed in direct contact
with RNA in RNP particles whose structures are incom-
pletely characterized. Cross-linking between RNA and pro-
teins can be achieved by incorporating base analogs (e.g.,
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5-bromo-20-deoxyuridine or 4-thio-uracil; Hicke et al.
1994; Sontheimer 1994; Meisenheimer and Koch 1997;
Meisenheimer et al. 2000) into the RNA, either site specifi-
cally or randomly; by chemical modification of the RNA
backbone (Konarska 1999); or by direct UV-irradiation at
254-nm wavelength (Go¨rner 1994). The latter method owes
its usefulness to the natural photoreactivity of RNA bases.
After the cross-linking reaction, cross-linked proteins can
be identified, for example, by their migration behavior in
SDS-PAGE (for [32P]-labeled RNA components in recon-
stituted RNP particles; Greuer et al. 1999; Reed and Chiara
1999; Expert-Bezancon et al. 2004), by their ability to react
with a specific antibody in Western blot analysis (Mo¨ller
and Brimacombe 1975; Dix et al. 1998), or by immunopre-
cipitation techniques (Urlaub et al. 2002; Hamon et al. 2004;
Bonnal et al. 2005). Although these techniques are highly
sensitive, none of them would be able to identify unex-
pected or unknown proteins in contact with the RNA.
Electrospray ionization (ESI) and matrix-assisted laser
desorption ionization (MALDI) mass spectrometry (Karas
and Hillenkamp 1988; Fenn et al. 1989) are by far the most
sensitive techniques available to sequence and subsequently
to identify novel proteins from a sample. Consequently, in
several studies, UV cross-linking has been combined with
mass spectrometry (MS) techniques in order to identify
proteins that are covalently linked to nucleic acids. In this
manner, proteins have been directly identified, for example,
from SDS-PAGE after they have been (site-specifically)
cross-linked to a [32P]-labeled DNA (Coman et al. 2004)
or RNA molecule (Rhode et al. 2003).
Although Jensen et al. (1993) successfully introduced the
analysis of peptide–ssDNA cross-links by MALDI-ToF MS
(but without sequencing), most of the preceding studies
used ESI MS to sequence peptide–nucleotide cross-links
by collision-induced dissociation (CID) (Smith et al. 1990),
while post-source decay (PSD) (Kaufmann et al. 1993) of
cross-linked heteroconjugates has rarely been performed.
Very recently, Geyer et al. (2004) reported the PSD
sequence analysis of a peptide–ssDNA cross-link where
the entire DNA moiety was completely hydrolyzed by
hydrofluoric acid, so that the cross-linked and subsequently
sequenced peptide only carried the DNA base. It should
also be noted that most of these MS studies investigated
DNA–protein cross-links (Golden et al. 1999; Wong and
Reich 2000; Steen et al. 2001; Coman et al. 2004; Doneau et
al. 2004), but only a very few dealt with RNA–protein cross-
links (Meisenheimer et al. 1996; Urlaub et al. 2002).
In recent years we have developed a purification strategy
that has enabled us to isolate peptide–oligoribonucleotide
cross-links directly from native RNP particles, such as small
nuclear ribonucleoprotein particles (snRNPs) (Will and
Lu¨hrmann 1997, 2001; Burge et al. 1999; Henras et al. 2004),
after these have been UV-irradiated at 254 nm (Urlaub et al.
2002) and subsequently treated with specific endoprotein-
ases and nucleases. However, this approach is subject to
limitations with regard to the sequence determination of
the purified cross-links—in particular, the sequence of the
cross-linked peptide moiety. Whereas the cross-linked RNA
part could be identified by a combination of MALDI-ToF
MS (in the linear mode and thus at a low resolution) and
primer-extension analysis on the cross-linked RNA, the
cross-linkedpeptide sequence and the actual cross-linked
amino acid could only be unambiguously identified by N-
terminal sequencing (Urlaub et al. 2002). Consequently,
large amounts of sample were necessary to obtain a quantity
of cross-linked material (5–10 pmol) sufficient for this type
of sequence determination.
MALDI-ToF MS seems ideally suited to establish a more
sensitive analytical approach, and it also offers the oppor-
tunity to reinvestigate samples on the target. Previous
MALDI analyses suffered from one major weakness,
though: The strongly divergent physico-chemical properties
of isolated peptide–RNA heteroconjugates made it difficult
to choose a suitable matrix for sample preparation. Further-
more, MALDI PSD analysis of (e.g., post-translationally)
modified peptides does not allow the establishment of rou-
tine protocols, and, in comparison with ESI MS/MS, it
requires much larger amounts of sample. Nonetheless we
chose to improve the MALDI-ToF MS methodology owing
to its above-mentioned advantages, and further to the fact
that MALDI-ToF MS dovetails perfectly with our estab-
lished purification protocol.
We therefore set out to find conditions for the MALDI-
ToF MS-based analysis of cross-linked complexes that gave
sufficient accuracy to allow the characterization of both the
peptide and the RNA moiety in peptide–RNA heterocon-
jugates. As starting material, we chose RNP subcomplexes
of the human splicing machinery with cross-linking prod-
ucts that have in parts been defined as: (1) [15.5K–61K–
U4atac] RNP particles prepared by reconstitution in vitro
(Nottrott et al. 2002) and (2) native U1 snRNP particles
(Kastner and Lu¨hrmann 1999), in order to gain confidence
in the new method.
Here, we describe our most recent advances in the com-
plete sequence determination (peptide and oligoribonu-
cleotide) of the cross-links derived from both these
particles, using MALDI-ToF MS only. The use of 20,40,60-
trihydroxyacetophenone monohydrate (THAP) and 2,5-
dihydroxy benzoic acid (DHB) as matrices enables us to
analyze the samples in an accurate manner in the reflectron
mode, and this in turn allows us (1) subsequently to per-
form mass comparisons with putative cross-linked peptide
and RNA stretches and, finally, (2) to perform PSD
sequence analysis in order to gain sequence and structural
information about the cross-linked components within a
single spectrum. Additionally, this method has enabled us
to gain insight into the UV-induced photoreaction between
an amino acid side chain and an RNA base. We consider
this analysis to represent a significant breakthrough for the
analysis of other RNPs, since it reduces the amount of
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sample required on the MALDI target by a factor of 50–100
down to 100 fmol of cross-linked sample, so that low-
abundance RNPs and cross-links obtained in lower yield
can be investigated.
RESULTS
2,5-DHB and 20,40,60-THAP matrices enhance peptide–
RNA oligonucleotide detection in MALDI-ToF-MS
Linear mode MALDI-ToF mass spectrometry has pre-
viously been used to characterize peptide–RNA oligonu-
cleotide cross-links at low mass spectrometric resolution
(Urlaub et al. 2000, 2001, 2002). To provide more detailed
characterization, we sought conditions that enable (1) an
accurate analysis of the cross-links’ intact molecular mass in
the reflectron mode and (2) PSD analysis to obtain struc-
tural information about the cross-linked moieties, both at
high sensitivity, that is, in the low femtomole range. We
therefore first tested various matrices for their ability to
produce highly accurate spectra from very small quantities
of cross-linked samples (25 mg of non-cross-linked starting
material). For this purpose we used [15.5K–61K–U4atac]
snRNP particles that had been prepared by reconstitution
in vitro (Nottrott et al. 2002) and native U1 snRNP parti-
cles. After UV irradiation of these particles, the protein
moiety was digested with the endoproteinases trypsin and/
or chymotrypsin. Intact RNA and RNA carrying cross-
linked peptides were separated from the excess of non-
cross-linked peptides by size-exclusion chromatogra-
phy, and the RNA-containing fractions were hydrolyzed
with RNase A and/or RNase T1. The final purification
step involved chromatography on a microbore C18 RP-
HPLC column, in which cross-linked peptide–RNA oligo-
nucleotides were separated from non-cross-linked RNA
oligonucleotides; the latter were mainly present in the
flow-through, while cross-linked peptide–oligonucleotides
eluted at a higher percentage of organic solvent and were
identified during chromatography by their UV absorbance
at 220 nm and 260 nm. Fractions showing an absorbance at
both of these wavelengths are considered to contain pep-
tides as well as RNA, and these were isolated and analyzed
by MALDI-ToFMS. The overall purification strategy is
summarized in Figure 1.
A sufficiently accurate analysis of the molecular mass of
the cross-linked heteroconjugates in those fractions should
enable us to determine the composition of the cross-linked
peptide and the RNA fragment by comparing the measured
mass of the cross-linked moiety with the theoretical masses
of (1) all possible chymotryptic/tryptic fragments of the
protein and (2) all possible RNase A/T1 fragments of the
RNA of the initial particle.
Figure 2 shows a comparison of results obtained with
various matrices for MALDI-ToF MS. We initially tested a-
cyano-4-hydroxycinnamic acid (CHCA), a ‘‘hot’’ matrix,
and observed a significant decomposition of cross-linked
peptide–RNA oligonucleotides produced by treatment with
RNase T1. Figure 2, A and B, shows the MALDI spectra
recorded in reflectron and linear modes, respectively, from
an RP-HPLC fraction containing a putative cross-linked
peptide–RNA oligonucleotide derived from UV-irradiated
[15.5K–61K–U4atac] RNP particles digested with chymo-
trypsin and RNase T1. Consistent with our earlier studies,
Figure 2 shows that cross-linked particles with a significant
RNA component (i.e., those obtained by digestion with
RNase T1) could only be detected in the linear mode
when CHCA was used as matrix. The linear mode, how-
ever, gave poor mass accuracy and no information about
isotopic patterns. This made it difficult to determine unam-
biguously the cross-linked components—in particular the
nucleotide composition of the cross-linked RNA oligonu-
cleotide, since nucleotides C and U differ in mass by only
one unit.
In contrast to the results obtained with CHCA, we were
able to obtain high quality spectra in the reflectron mode
when using DHB or THAP as matrices. Strikingly, both
matrices dramatically enhance the intensity of the quasi-
molecular ion [M + H]+ of the isolated cross-linked species
observed at a monoisotopic m/z of 2780.818 (Fig. 2C,D).
The THAP preparation showed the highest sensitivity and
the lowest amount of spontaneous fragmentation of the
analyte (Fig. 2D). Both DHB and THAP preparations
yielded resolutions higher than 15,000 FWHH (full width
at half height). The mass accuracy with close external cali-
bration was evaluated with standard peptides and found to
be 50 ppm or better with both matrices. The enhanced
sensitivity together with the high resolution and accuracy
enabled us to determine the compositions of the cross-
linked peptide and RNA moieties. Importantly, we also
analyzed cross-linked samples in the negative mode with
THAP as matrix. Previous work by Zhu et al. (1996) de-
monstrated that oligonucleotides analyzed in the negative
linear mode with THAP as matrix gave excellent results in
terms of signal intensity. We also observed an increase in
signal intensity of the cross-linked precursor in the negative
reflectron mode compared with the positive reflectron
mode (data not shown). However, we did not use these
conditions for further analysis of cross-links, since PSD
analysis in the negative mode (data not shown) only
showed poor fragmentation of the cross-linked peptide
moiety.
Accurate mass determination of the cross-linked
moiety by high-resolution MALDI-ToF spectra
using THAP and DHB as matrix
We used THAP and DHB preparations for the accurate
mass determination of peptide–RNA cross-links. Figure
3A shows the isotopically resolved quasimolecular ion
region of a cross-linked peptide–oligonucleotide obtained
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after treatment of the initially UV-irradiated particles with
chymotrypsin and RNase T1 at m/z 2780.818. The sample
was measured in the reflectron mode using THAP as matrix
and close external calibration. To determine the peptide
and RNA composition, we compared all chymotryptic frag-
ments of the protein moiety with all RNase T1 fragments of
the U4atac RNA moiety. We found that the measured
monoisotopic mass matches accurately with only one chy-
motryptic fragment of the 61K protein, encompassing pro-
tein positions 263–273 (SSTSVLPHTGY Mcal = 1147.551),
and with only one RNase T1 fragment of U4atac RNA,
comprising nucleotide positions C42–G46 (50-CAUAG-30,
Mcal = 1632.227). Assuming additive behavior of the pep-
tide and RNA molecular masses from the cross-linking reac-
tion, the mass accuracy was found to be 28 ppm. The next best
hit from this calculation (61K protein positions 215–232,
Mcal = 1782.019, and U4atac RNA nucleotide positions
C53–G55, Mcal = 997.150) has a significantly higher mass
deviation (132 ppm) and was thus not considered to be
the actual cross-linked complex. From this analysis we con-
clude that protein 61K must be cross-linked to U4atac
RNAbetween residues 263 and 273 on the protein and nucleo-
tides C42 and G46 on the RNA.
MALDI-ToF MS analysis of another RP-HPLC fraction
obtained by digestion of UV-irradiated [15.5K–61K–
U4atac] RNP particles with chymotrypsin and RNases A
and T1 revealed a peak at m/z 1801.646 (Fig. 3B),
corresponding within 22 ppm to the same chymotryptic
peptide of protein 61K comprising the same positions
263–273 (SSTSVLPHTGY, Mcal = 1147.551) cross-linked
to an AU (Mcal = 653.087) dinucleotide. Six such AU
dinucleotides are present in the sequence of the U4atac
snRNA (A5–U6, A35–U36, A43–U44, A85–U86, A117–
U118, and A129–U130). Notably, A43–U44 is located
within the cross-linked T1–oligonucleotide CAUAG,
encompassing nucleotide (nt) positions 42–46. We there-
fore conclude that 61K protein is cross-linked to this
particular dinucleotide on the U4atac snRNA.
In addition, we isolated a putative cross-link after diges-
tion of UV-irradiated trimeric RNP complexes with trypsin
and RNases A and T1 from the RP-HPLC. MALDI-ToF
analysis revealed two major peaks at m/z 3535.489 and m/z
3260.444. However, a database search gave no positive
result for any tryptic fragment cross-linked to an RNaseA/
FIGURE 1. Schematic representation of the purification of cross-
linked peptide–RNA oligonucleotides derived from ribonucleopro-
tein particles, either native or prepared by reconstitution in vitro.
The RNP particles are UV–irradiated and then made to dissociate.
Subsequently, the protein moiety is digested with endoproteinases
trypsin or chymotrypsin. RNA that carries cross-linked peptides
and intact RNA are separated from non-cross-linked peptides by
size-exclusion (SE) chromatography. RNA-containing fractions are
hydrolyzed with ribonucleases A and/or T1, and the resulting
mixture of non-cross-linked oligonucleotides and cross-linked pep-
tide–RNA oligonucleotides is subjected to a final purification step
by RP-HPLC. Fractions showing an absorbance at 220 nm and
260 nm are presumed to contain cross-linked peptide–RNA hetero-
conjugates and are thus analyzed in the MALDI-ToF mass spectro-
meter.
1918 RNA, Vol. 11, No. 12
Ku¨hn-Ho¨lsken et al.
FIGURE 2. Comparison of different matrices for the analysis of cross-linked peptide–RNA heteroconjugates in MALDI-ToF. Equal volumes of
cross-links in RP-HPLC fractions were mixed with different matrices and analyzed by MALDI-ToF mass spectrometry under various conditions: (A)
with CHCA as matrix and analysis in the reflectron mode; (B) with CHCA as matrix and analysis in the linear mode; (C ) with DHB as matrix and
analysis in the reflectron mode; and (D) with THAP as matrix and analysis in the reflectron mode. Cross-links are derived from UV-irradiated
[15.5K–61K–U4atac] RNPs after treatment with chymotrypsin and RNase T1, and thus are expected to carry a larger RNA moiety. All the spectra
were recorded on a Voyager DE-STR MALDI mass spectrometer (Applied Biosystems) under standard conditions. In A and B, the inset shows
magnified the m/z values that are expected to show a mass peak from the putatively cross-linked species.
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T1 fragment of the U4atac snRNA, either from protein 61K
or from protein 15.5K. This result illustrates the fundamen-
tal need for structural information about the cross-linked
species, as yielded by PSD analysis (see below).
Figure 3C gives a third example of the determination of
the cross-linked peptide and RNA moieties from a single
MS spectrum under the improved conditions that we describe.
This spectrum shows the MALDI-ToF MS analysis of an RP-
HPLC fraction containing a cross-link derived from native
UV-irradiated U1 snRNPs treated with trypsin and RNase
T1. We observed several predominant peaks (a–e, see Fig.
3C). By comparing all possible tryptic fragments from the 10
U1 proteins (70K, U1A, U1C, and the Sm proteins B/B0, D1–
D3, E, F, and G; Will and Lu¨hrmann 2001) with all possible
U1 snRNA RNase T1 fragments in a database search, we
found that these peaks correspond to a U1 70K tryptic frag-
ment from positions 173–180 (RVLVDVER, Mcal = 984.572)
cross-linked to a U1 snRNA T1 fragment encompassing posi-
tions 29–34 (50-AUCACG-30, Mcal = 1937.268) and to 30
hydrolysis products of the latter (see the table in Fig. 3C).
Notably, the mass accuracy over the entire spectrum is >30
ppm with close external calibration.
Note that our database search with the highest precursor
of m/z 2922.928 gave several other hits with a similar mass
accuracy: (1) residues 238–246 of protein U1-70K (ERER-
RERSR,Mcal = 1272.675) putatively cross-linked to nt 77–81
of U1 snRNA (50-AUGUG-30, Mcal = 1649.206) with a mass
accuracy of 12 ppm, and (2) positions 85–92 of protein Sm
D2 (KKSKPVNK, Mcal = 927.587) putatively cross-linked to
nt 76–81 of U1 snRNA (50-GAUGUG-30, Mcal = 1994.256)
with a mass accuracy of 26 ppm. We consider these combi-
nations to be highly unlikely, as our analysis unambiguously
reveals the stepwise loss of the nucleotides G, C, A, and C.
The alternative RNA oligonucleotides (50-AUGUG-30 and 50-
GAUGUG-30, respectively) should have shown two losses of
U, which were not observed in this experiment. The latter
reason again illustrates the substantial improvement that is
achieved by using matrices that allow the recording of spec-
tra of peptide–RNA heteroconjugates with a high accuracy in
the reflectron mode. Note that without any previous knowl-
edge of sequence information and under nonimproved
MALDI conditions (i.e., analysis in the linear mode), the
observed hydrolysis products of the RNA part would also
have matched the alternative RNA sequences, since measur-
ing in the linear mode does not allow one to distinguish
between C and U, which differ in mass by only one unit.
PSD analysis of cross-linked peptide–RNA
heteroconjugates
Having established conditions for the sensitive and accurate
analysis of peptide–RNA cross-links in the reflectron mode
using THAP (or DHB) as matrix, we next performed PSD
analysis on the putative peptide–RNA heteroconjugates to
obtain further structural information about the cross-
linked species.
Figure 4A demonstrates that our THAP (DHB) prepara-
tion also showed excellent properties in the PSD analysis of
the selected peptide–RNA oligonucleotide precursors. Fig-
ure 4A shows the PSD analysis of the precursor at m/z
2780.818; this was calculated as being the spliceosomal
61K protein (positions 263–273) cross-linked to a penta-
nucleotide 50-CAUAG-30 (nt 42–46) of the U4atac snRNA.
Strikingly, the fragment pattern obtained yields significant
sequence information about the cross-linked RNA moiety.
Figure 4B shows the relationship between the measured
fragment ions and the RNA sequence, according to the
nomenclature introduced by McLuckey et al. (1992).
A stepwise fragmentation of the oligonucleotide moiety
from both its 50 and its 30 ends can be observed up to the
cross-linked base in the PSD spectrum; them/z values of the
ions consistently represent the mass of the remaining RNA
moiety added to the mass of the intact cross-linked peptide
sequence. The m/z values of the fragment ions a and b
represent losses of cytosine and guanine, respectively, indi-
cating that a cytidine is at the 50 end and a guanosine is at
the 30 end (RNase T1 cleavage site). Together with the
observed losses of nucleotides C and A and of a dinucleo-
tide AG, these findings both support the assignment of the
RNA fragment to the sequence 50-CAUAG-30 as previously
calculated.
FIGURE 3. Highly resolved mass peaks of purified peptide–oligoribonucleotides allow the calculation of the mass of the putatively cross-linked
peptide and RNA parts. (A)Highly resolved mass peak of a purified cross-link derived from UV-irradiated [15.5K–61K–U4atac] RNPs treated with
chymotrypsin and RNase T1. The spectrum was recorded in the reflectron mode with THAP as matrix. From the measured monoisotopic mass we
calculated the listed peptide sequence of the protein 61K cross-linked to an RNase T1 fragment of U4atac snRNA. The mass deviation is less then
30 ppm. The next best hit from such a calculation is also listed; notably, the mass deviation is already 132 ppm. (B) Highly resolved mass peak of a
purified cross-link derived from UV-irradiated [15.5K–61K–U4atac] RNPs treated with chymotrypsin and RNases A/T1. From the measured
monoisotopic mass we calculated the listed cross-linked sequences of protein 61K and U4atac snRNA. As in spectrum A, the mass deviation is <30
ppm. Note that the peak at m/z 1783.667 is caused by the loss of water upon formation of 20,30-cyclic phosphates at the 30 end of the cross-linked
RNA. (C) Highly resolved mass spectrum of a purified cross-link derived from UV-irradiated U1 snRNPs treated with endoproteinase trypsin and
RNase T1. The measured monoisotopic masses match precisely a tryptic fragment of the U1 protein 70K from positions 173–180 cross-linked to a
U1 snRNA T1 fragment from positions 29–34 and to its 30-hydrolysis products, respectively. Notably, the mass accuracy over the entire spectrum is
again >30 ppm. All spectra were recorded in the reflectron mode. A and C were recorded on a Voyager DE-STR MALDI mass spectrometer
(Applied Biosystems) under standard conditions using THAP as matrix. Spectrum B was recorded on a Reflex IV MALDI mass spectrometer
(Bruker Daltonics) with DHB as matrix.
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Starting from fragment ion e, which represents the peptide
carrying a CAU trinucleotide, one can follow the stepwise
loss of the components of the nucleotides, that is, phosphates
(Dm = 80/98), riboses (Dm = 114), and bases (Dm = 111
[C0], and 135 [A0]) up to the most prominent fragment l,
which represents the peptide moiety cross-linked to a uracil.
In the low-mass region of the PSD spectrum, complete
fragmentation of the separate AG dinucleotide is observed
(fragment ions m–r).
These PSD results demonstrate clearly that the cross-
linked RNA part is indeed the pentanucleotide T1 fragment
50-CAUAG-30, nt 42–46 of the U4atac snRNA, which we
calculated from the reflectron mode analysis. Moreover, we
did not observe any loss of uridine or uracil, suggesting that
U44 within the T1 fragment is the actual cross-linked
nucleotide. Figure 4C summarizes schematically the ob-
served fragmentation.
The PSD analysis of this precursor gave no sequence or
structural information about the cross-linked peptide moi-
ety. This result is not unexpected, as the relatively large
oligoribonucleotide moiety easily fragments under PSD
conditions and interferes with the detection of peptide
fragments. A similar phenomenon was observed in ESI-
CID analysis of a peptide-ssDNA cross-link (Golden et al.
1999; Steen et al. 2001). Comparable behavior is frequently
observed during the analysis of glycosylated peptides (Blom
et al. 2004; Zaia 2004; Zamfir and Peter-Katalinic 2004).
By performing PSD analysis of the smaller precursor at
m/z 1801.646, which was provisionally assigned to the same
peptide sequence being cross-linked to the shorter AU
dinucleotide, we obtained sequence information about the
cross-linked peptide. Figure 5A shows the corresponding
PSD spectrum, and the results are summarized in Figure
5B. The spectrum shows a b-type fragment ion series of the
cross-linked peptide from b3 to b7, revealing the peptide
sequence TSVLP, and RNA fragments of w- and y-type,
namely w1, ym, and ymw1, carrying the entire cross-
linked peptide, as well as several combinations of these
RNA fragments with peptide fragments of the y-series.
Furthermore, the loss of adenine (Dm = 135) and adeno-
sine (Dm = 329) and its sugar phosphate identifies uridine
within the dinucleotide as the actual cross-linked nucleo-
tide. Importantly, we observed a y-type series y3–y6 with the
resulting sequence LPHT (Fig. 5B). The absolute m/z values
of this series indicate that peptide fragments are covalently
linked to an AU dinucleotide or a U mononucleotide. Strik-
ingly, the fragment with the observed m/z of 444.2 corre-
sponds to a His–Uridine heteroconjugate, suggesting that
His270 in the spliceosomal 61K protein is the amino acid
actually cross-linked to U44 in the U4atac snRNA. Figure 5C
summarizes the results schematically. Interestingly, the fact
that we observed a fragment ion that corresponds to a His–
Uridine conjugate illustrates that the cross-link reaction
must be a radical-induced addition without loss of any H-
radical in either component, histidine or uridine. We thus
assume that the reaction takes place by a mechanism similar
to that proposed by Norris et al. (1996, 1997) who used 5-
halogen- (bromo- or iodo-) substituted uracil bases, with the
exception that in our case the radical-induced formation of
the novel covalent bond between the amino acid and the
uracil base leads presumably to the opening of the C–C
double bond in the uracil base, as no radical-induced loss
of hydrohalide acids is possible.
As mentioned above, we isolated two other putative
peptide–RNA oligonucleotides from the UV-irradiated
[15.5K–61K–U4atac] trimeric complex after digestion
with trypsin and RNases A/T1. However, our calculations
based on the measured masses (m/z 3260.444 and m/z
3535.489) did not reveal any specific tryptic fragment
derived from either the 61K or 15.5K protein cross-linked
to an RNase A/T1 oligonucleotide of U4atac snRNA. Figure
6A shows the PSD sequence analysis of one of these partic-
ular precursors (m/z 3260.444). The PSD spectrum shows
an almost complete series of y-type fragments up to y18,
revealing the sequence TGYIYHSDIVQSLPPDLR. Thus, in
combination with the measured precursor mass and the
observed losses of adenine and adenosine in the PSD spec-
trum, we iden-tified this precursor as a cross-link between
protein 61K (positions 266–288, SVLPHTGYIYHSDIVQ
SLPPDLR, Mcal = 2606.350) and an AU dinucleotide (pre-
sumably A43 and U44, Mcal = 653.087). The missing y19
(H) indicates that His270 is the actual cross-linked amino acid
(Fig. 6B). Again, the losses of adenine and adenosine demon-
strate that the peptide is cross-linked via the uracil rather
than the adenine base. PSD analysis of the other precursor
at m/z 3535.489 showed exactly the same y-type fragmen-
tation for the peptide sequence (up to y18) and w-, yr-, and
a-type fragmentation for the cross-linked RNA. Thus, the
larger precursor mass is the same peptide–RNA cross-
link with three additional amino acids at its N terminus
FIGURE 4. Sequence analysis of a peptide–RNA cross-link derived from UV-irradiated [15.5K–61K–U4atac] RNPs after hydrolysis with
chymotrypsin and RNase T1. (A) PSD spectrum of a cross-linked precursor (m/z 2780.818) with DHB as matrix. The spectrum reveals significant
sequence information about the cross-linked RNA moiety, but shows no fragmentation of the peptide. The measured fragment ions are related to
the RNA sequence in the table in Figure 2B according to the nomenclature introduced by McLuckey et al. (1992), revealing the RNA sequence 50-
CAUAG-30 as previously calculated. (B) Fragment ions found in the PSD spectrum of the precursor at m/z 2780.818 (see A). Asterisks next to
fragments indicate that the measured fragment masses represent RNA fragments with cross-linked peptide moiety. Y-type RNA fragment ion series
are named yr1 to yrn. Peaks g, h, and i allow several combinations of fragments and sequences, as indicated by the braces. (C) Schematic
representation of the cross-link with the sequence of the U4atac snRNA and of the U4/U6 snRNP-specific 61K protein (hPrp31p). The
fragmentation types of the RNA are indicated. Since no sequence information about the cross-linked peptide part was obtained under these
conditions, the calculated peptide sequence is shown in brackets.
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(263SSTSVLPHTGYIYHSDIVQSLPPDLR288, Mcal = 2881.461).
Remarkably, the PSD analysis identified both peptides as
nonspecific tryptic fragments of the 61K protein (Fig. 6B).
Moreover, the fact that the AU dinucleotide (with a cross-
linked U) results from an RNase A/T1 cleavage is also
surprising; it may indicate that the covalently modified U
is a substrate for RNases. We can exclude any nuclease
activity derived from trypsin, as we exclusively isolated
61K fragments cross-linked to the RNA pentanucleotide (but
no 61K fragments cross-linked to an AU dinucleotide) when
UV-irradiated particles were treated with trypsin and RNase
T1 only (data not shown). Such unspecific enzymatic cleavage
and possible mass-spectrometric gas-phase fragmentation
events must be considered in database searches when, prior
to sequence analysis, putative cross-links are calculated by
comparing endoproteinase fragments of the proteins with
nuclease fragments of the cognate RNAs.
The results from both the MS and the PSD analyses of the
cross-links derived from the [15.5K–61K–U4atac] trimeric
complex reconstituted in vitro are absolutely consistent with
the results from our former studies (Urlaub et al. 2000,
2002). By combining N-terminal sequencing and linear
mode MALDI mass spectrometry, we showed that the U4/
U6 snRNP-specific 61K protein (hPrp31p) cross-links to the
50 stem–loop of U4atac snRNA between nucleotide positions
C42 and G46. The cross-linked peptide region was identified
by N-terminal sequencing, and His270 was found to be the
actual cross-linked amino acid. Our studies presented here
extend the earlier findings. We demonstrate that, without the
need of alternative/additional sequencing methods, we are
able to obtain sequence and structural information about the
cross-linked peptide and RNA moieties and thus to identify
unambiguously the actual cross-linking site on the peptide,
His270, and on the RNA, U44.
FIGURE 5. Sequence analysis of a peptide–RNA cross-link derived from UV-irradiated [15.5K–61K–U4atac] RNPs after hydrolysis with chymo-
trypsin and RNases A/T1. (A) PSD spectrum of a cross-link with a precursor of m/z 1801.581. The spectrum was recorded with DHB as matrix. It
shows a b-type fragment ion series of the cross-linked peptide from b3 to b7, revealing the peptide sequence TSVLP and RNA fragments of w and yr
types, along with several combinations of these RNA fragments with peptide fragments of the yp series; altogether this suggests that histidine 270 in
the 61K protein is the amino acid actually cross-linked to nucleotide U44 in the U4atac RNA. (B) Fragment ions found in the PSD spectrum of the
precursor at m/z 1801.584 (see A). Fragmentation nomenclature is according to McLuckey et al. (1992) except that fragmentation at the 30-terminal
phosphate is denoted as w1. Asterisks next to fragments indicate that the measured fragment masses represent RNA fragments with cross-linked
peptide moiety. (C) Schematic representation of the cross-link with the sequences of the U4atac snRNA and of the U4/U6 snRNP-specific 61K protein
(hPrp31p). The fragmentation types of the RNA are indicated. Since we observe Y-type fragmentation of both peptide and RNA, we refer to these as
yp and yr, respectively.
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Another example of the PSD analysis of a putatively
cross-linked precursor is given in Figure 7A. In our MS
studies shown in Figure 3C, the precursor at m/z 1638.666
marked as signal e was assigned to contain a tryptic U1–70K
fragment encompassing positions 173–180 cross-linked to
an AU dinucleotide, namely A29–U30. The PSD analysis
indeed confirmed our calculation for this cross-link, as we
observed several fragment ions and immonium ions of the
expected peptide sequence. Despite the fact that the PSD
spectrum is not of optimal quality, it provides enough
sequence information (fragment ions
yp1–yp5, yp7 plus RNA) to prove that
the calculated peptide sequence is
indeed RVDVLVER. Consequently, the
cross-linked AU dinucleotide must be
A29–U30 according to Figure 3C, with
the U30 cross-linked, as revealed by the
loss of adenine and adenosine in the
PSD spectrum. The lack of the yp6-frag-
ment ion together with the appearance
of yp7 plus RNA—although the latter is
very weak—points to L175 as the amino
acid actually cross-linked. Figure 7C
summarizes the results schematically.
This analysis demonstrates that a sensi-
tive and accurate MALDI-ToF analysis
is a prerequisite for the identification of
the cross-linked species and their
sequences by PSD analysis.
SUMMARY AND CONCLUSIONS
In this study we have established that it is
possible to identify the complete structure
of purified peptide–RNA cross-links sole-
ly by MALDI-ToF mass spectrometry.
The analysis is based on a four-step
strategy starting with the purification
of peptide–RNA oligonucleotide cross-
links from in vitro reconstituted and/or
native ribonucleoprotein particles after
UV irradiation according to our pre-
vious studies (see Fig. 1; Urlaub et al.
2000, 2001, 2002). Purified cross-links
are then analyzed by MALDI-ToF in the
reflectron mode under improved condi-
tions. The accurate intact mass obtained
from this analysis is used for a database
search to reveal a list of putative cross-
links, and finally PSD sequence analysis
is applied to confirm the structure of the
cross-link, including its peptide and
RNA parts and the actual cross-linking
site.
In this manner we examined the cross-
linked peptide and RNA moieties in peptide–RNA oligonu-
cleotides derived from UV-irradiated [15.5K–61K–U4atac]
RNP complexes prepared by reconstitution in vitro and
native U1 snRNP complexes and identified the actual
cross-linking sites, namely His270 in the U4/U6 snRNP-
specific 61K protein (hPrp31) cross-linked to U44 in the
U4atac snRNA and Leu175 in the U1 snRNP specific 70K
protein to U30 in the U1 snRNA. The identified cross-link-
ing sites have been independently established in former stud-
ies by different analysis techniques (see above) and, in the
FIGURE 6. Sequence determination of a peptide–RNA cross-link derived from UV-irradiated
[15.5K–61K–U4atac] RNPs after hydrolysis with trypsin and RNases A/T1. (A) PSD spectrum
of a cross-link precursor (m/z 3260.444). The spectrum was recorded with THAP as matrix.
The PSD spectrum shows an almost complete series of y-type fragments up to y18, revealing the
sequence TGYIYHSDIVQSLPPDLR. In combination with the observed losses of adenine and
adenosine in the spectrum, PSD analysis identified this precursor as nontryptic peptide from
protein 61K (SVLPHTGYIYHSDIVQSLPPDLR) cross-linked to an AU dinucleotide. The
missing y19 (H) indicates that His270 is the actual cross-linked amino acid; the loss of adenine
and adenosine suggests that the U rather than the A of the dinucleotide is the actual cross-
linked nucleotide. The fragment ions found are directly assigned in the spectrum. (B) Sche-
matic representation of both the U4atac snRNA nucleotides and the tryptic peptide of the U4/
U6 snRNP-specific 61K protein (hPrp31p). Observed fragmentations within the peptide and
the RNA parts are indicated. For details, see the legend of Figure 5.
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case of the U1 70K protein, a model of the protein with its
cross-linking sites to the U1 snRNA has been proposed
(Urlaub et al. 2000).
The human U4/U6 snRNP-specific 61K protein (hPrp31p)
belongs to the Nop family of proteins, which also includes
the box C/D snoRNP proteins Nop56 and Nop58 (Tran et al.
2004) and the archaeal homolog of these proteins, Nop5p.
Recently, the crystal structure of the archaeal protein Nop5p
in complex with fibrillarin was determined (Aittaleb et al.
2003; Fig. 8A). The C-terminal part of Nop5p constitutes the
most strongly conserved region of the protein and is part of
the so-called Nop domain (Makarova et al. 2002). Owing to
accumulation of positively charged residues on the surface of
this domain, the authors speculated that this region might be
involved in direct interaction with the cognate archaeal box
C/D RNA. Strikingly, the cross-linked His270 of the U4/U6
snRNP-specific 61K protein (hPrp31p) matches residue
Lys209 of Nop5p, which is located within this conserved
region of the protein (Fig. 8B). Residue Lys209 of Nop5p is
the last amino acid in a disordered loop within the Nop
domain. Its approximate location can be inferred from the
position of the following residue, which is ordered in the
crystal structure (Fig. 8A). This observation is notably con-
sistent with the general trend that cross-linkable regions of
proteins are often located in loop regions (Urlaub et al. 1995,
2000). Such loop regions might have enough flexibility to
allow the formation of a novel covalent bond between the side
chain of an amino acid and the base of a nucleotide on the
RNA in the vicinity.
We consider the entirely MS-based analysis presented here
to be of great importance not only for the identification of
putative RNA binding regions in proteins (as described
above), but also for future studies of hitherto noncharacter-
ized and low abundant protein–RNA complexes directly iso-
lated from cells for two reasons: First, due to the im-
provements in sensitivity by a factor of 50–100 so that 100
fmol of cross-linked peptide–RNA oligonucleotide on the
MALDI target is sufficient, it is obvious that the starting
amount for such an analysis can be drastically reduced accord-
ingly and/or that samples with a lower cross-linking yield can
FIGURE 7. PSD spectrum of a cross-link (precursor m/z 1638.666) derived from UV-irradiated U1 snRNPs treated with endoproteinase trypsin
and RNases A and T1. (A) The PSD spectrum shows a series of yp-type ions from the cross-linked peptide (yp1–yp5), revealing the sequence
VDVER. In combination with Figure 3C and the observed losses of adenine and adenosine, we identified this precursor as a cross-link of a tryptic
U1–70K fragment encompassing positions 173–180 cross-linked to an AU dinucleotide, encompassing positions A29–U30 on the U1 snRNA. The
measured fragment ions are related to the peptide and the RNA sequence in panel B. The spectrum was recorded on a Bruker Ultraflex MALDI
ToF/ToF under standard PSD conditions. (B) Fragment ions found in the PSD spectrum of the precursor of m/z 1638.666 (see above). Asterisks
beside fragment ions indicate RNA fragments cross-linked to peptide. For details, see the text and the legend of Figure 5. (C) Schematic
representation of the RNA and peptide sequences of the identified cross-link. Observed fragmentation in the PSD analysis is indicated.
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be investigated. Second, establishing theMS-based sequencing
obviates the need of additional experiments to elucidate
sequence and structure of the cross-linked components.
The first achievement gained in this analysis is the sensitive
and highly accurate analysis of cross-links in the reflectron
mode by MALDI-ToF mass spectrometry with THAP or
DHB as matrices. Monoisotopic resolution can be achieved
up to 6000 m/z, enabling mass accuracies of >50 ppm even
with external calibration. At this degree of accuracy the
cross-linked species can often be assigned
to a certain protein in a restricted data-
base search simply by combining mono-
isotopic masses of peptide fragments
with monoisotopic masses of RNA frag-
ments. Even if no unambiguous assign-
ment can be made based on intact mass
alone, the achieved accuracy might
already be sufficient to narrow down
the analysis significantly. It is obvious
that the number of false positives will
steadily increase with the number of pro-
teins in larger RNP complexes (e.g., the
spliceosomal 17S U2 or 25S [U4/U6.U5]
snRNP), thus increasing the importance
of reducing ambiguity of the assignment
to an absolute minimum. In cases where
either no hit (e.g., due to unspecific
cleavage of the peptide and/or RNA) or
too many hits in a database search are
obtained, sequence information of either
the cross-linked RNA or, more impor-
tantly, the cross-linked peptide species is
an absolute requirement for the unam-
biguous assignment of the cross-links.
Therefore, the second improvement
in our approach is the PSD analysis of
cross-links, which reveals sequence in-
formation about the cross-linked pep-
tide and RNA moieties and, ultimat-
ely, the actual site of cross-linking.
Sequencing of the cross-linked pep-
tide component has always been the
bottleneck in previous analyses (Urla-
ub et al. 2000, 2001, 2002), mainly be-
cause too much sample was required
for, for example, automated N-terminal
sequencing, and the very different phy-
sico-chemical properties of the various
cross-linked species made it difficult to
find appropriate MALDI MS conditions
for sequence analysis. Here, PSD analy-
sis with THAP or DHB as matrices
has the main advantage that when pep-
tide–RNA heteroconjugates with cross-
linked di- or trinucleotides (i.e., rela-
tively short RNA fragments) are being studied, sequence
information about both the peptide and the RNA moieties
can be obtained in a single experiment under standard
conditions.
In a recent study, Geyer et al. (2004) sequenced the
peptide part of a peptide–ssDNA cross-link by PSD, but
in this particular case the DNA moiety was completely
hydrolyzed by hydrofluoric acid, so that the peptide carried
only the base, and DNA sequence information was lost.
FIGURE 8. The cross-linked amino acid His270 of the U4/U6 snRNP-specific 61K protein
(hPrp31p) matches residue Lys209 in the central Nop56/Nop58 homology domain of the
protein Nop5p from Archaeoglobus fulgidus, the archaeal homolog of the human box C/D
snoRNP proteins Nop56p/Nop58p and the U4/U6 snRNP-specific 61K protein (hPrp31p). (A)
Schematic representation of the cross-linking site between U44 (shown in red) in the 50 stem–
loop of the human U4atac snRNA and the disordered loop within the Nop domain of the
crystal structure of the Nop5p protein of A. fulgidus. Amino acid Lys209 (marked with a red
ball) in the crystal structure of the archaeal Nop5p (Aittaleb et al. 2003) corresponds in the
sequence alignment to His270 of the human 61K protein, which is found to be cross-linked to
U4atac snRNA (see B). The parts of the crystal structure highlighted in dark blue represent the
C-terminal part of the Nop56p/Nop58p homology domain of the Nop5p protein from a-
helices a6 to a12. See the text for details. (B) Alignment of the C-terminal part of the Nop
domain of the human U4/U6-snRNP-specific 61K protein (hPrp31p, residues 217–328; Makar-
ova et al. 2002, acc. no. NP_056444) with the homologous sequences of the human C/D box
snoRNP proteins Nop56p (amino acids 301–412, acc. no. Y12065), Nop58p (amino acids 285–
396, acc. no. AF123534), and of the archaeal homolog of human Nop56p/Nop58p, Nop5p,
(amino acids 151–267; Aittaleb et al. 2003; acc. no. NP_070912). Amino acids marked by an
arrow represent the position of the residue highlighted in the crystal structure (A. fulgidus
Nop5p, Lys209; see A) and the corresponding cross-linked amino acid His270 in the 61K
protein (hPrp31p). Sequence alignments were performed by using the Clustal method. Iden-
tical residues are boxed in black; conserved residues are highlighted in gray.
Fi 8 li 4/
www.rnajournal.org 1927
MS sequence analysis of peptide–RNA cross-links
We further did not test 3-hydroxypicolinic acid (3-HPA)
as MALDI matrix for our purpose. 3-HPA is suitable for
MALDI analysis of nucleotides (Wu et al. 1994; Vallone et
al. 2004), but shows poor ionization response for peptide
analytes. Furthermore, in a similar MALDI analysis of post-
translational modifications in RNase A and/or T1 frag-
ments of prokaryotic ribosomal 5S rRNA (Kirpekar et al.
2000), the authors observed that 3-HPA was useful only
when higher m/z ranges were considered, while only THAP
showed good properties in the lower and middle m/z
ranges.
Despite these achievements in the sequencing of the
peptide–RNA oligonucleotide cross-links and the overall
advantages of MALDI MS—sensitivity, mass accuracy, sam-
ple preparation, and ease of instrument handling—some
critical points also have to be taken into account. Sequence
information about the cross-linked peptide is only obtained
from PSD analysis when the cross-linked RNA moiety is
relatively small, that is, after digestion with RNases A and
T1. In this case, fragmentation of the peptide backbone
dominates the PSD spectrum.
The sequencing of cross-links with larger RNA frag-
ments revealed the RNA sequence, but no information
about the peptide as in similar investigations of cross-
linked peptide–ssDNA conjugates by ESI MS/MS. Under
standard conditions information mainly about the cross-
linked di- or trinucleotide ssDNA oligomers was obtained,
while the parts of cross-linked peptide sequence were
obtained only after drastic changes in the collision energy
(Steen et al. 2001). Unfortunately, PSD analyses do not
offer any instrumental parameters to adjust the fragmen-
tation conditions accordingly. High-energy collision-
induced dissociation experiments on MALDI-ToF/ToF
instruments might offer improved MS/MS capabilities
for this purpose.
Since RNAs often contain repetitive di- and trinucleo-
tide (and even longer) sequence stretches, it is difficult
to map the exact cross-linked region on the RNA by
only one experiment, when no cross-linkable site-specific
label on the RNA has been introduced. However, when
one is investigating native RNP particles—for example,
with a view to discovering which proteins are in contact
with the RNA at all or in the search for new RNA
binding motifs in proteins—the cross-linked RNA frag-
ment does not need to be long. In studies of this kind,
our method—coupled with PSD—is the method of
choice, and we plan to exploit its potential in future
studies of RNAs with dynamic protein binding patterns
and of low-abundance RNPs.
With the establishment of PSD analysis, the sequencing
of low-abundance cross-links and cross-links derived
from low-abundance protein–RNA complexes is possible.
Further improvements in UV cross-linking and in purifica-
tion of the cross-linked samples will be necessary in order to
exploit this method to the full.
MATERIALS AND METHODS
Chemicals and reagents
Water, acetonitrile, ethanol, sodium chloride, magnesium chlo-
ride, ethylenediaminetetraacetic acid disodium salt (EDTA), urea,
and sodium dodecylsulfate (SDS) were obtained from Merck.
Trifluoroacetic acid (TFA), CHCA, and 20,40,60-THAP were pur-
chased from Fluka, 2-[4-(2-hydroxyethyl)-1-piperazinyl]-ethane
sulfonic acid (HEPES) from Calbiochem, 2,5-dihydroxy benzoic
acid (DHB) from Sigma-Aldrich, RNases A and T1 from Ambion,
chymotrypsin from Roche, and porcine trypsin from Promega.
CHCA was recrystallized from dry ethanol. Peptide standard cali-
bration mixture was obtained from Bruker.
Sample preparation
Samples containing cross-linked peptide–RNA oligonucleotide
heteroconjugates were purified according to Urlaub et al. (2000,
2001, 2002). Briefly, spliceosomal ternary [15.5K–61K–U4atac]
RNP complexes obtained by reconstitution in vitro (Nottrott
et al. 2002) or native spliceosomal U1 snRNP particles were UV-
irradiated at 254 nm. The protein moiety was digested with endo-
proteinases trypsin and/or chymotrypsin. RNA cross-linked to
peptides together with intact RNA was separated from the excess
of non-cross-linked peptides by size-exclusion chromatography on
an HR75 column coupled to a SMART system (Amersham Phar-
macia Biotech/GE Healthcare). Fractions containing RNA were
digested with ribonucleases T1 and/or A. Peptide–oligoribonu-
cleotide species were purified from the mixture by RP-HPLC
with a C2/C18 column (100 mm 3 2.1 mm; GraceVydac) coupled
to a SMART system or with an RP C18 column (150 mm 3 0.3
mm; MicroTech Scientific) coupled to a 140C microgradient sys-
tem (Applied Biosystems) running at a flow rate of 2 mL/min.
Gradients of water/0.1% TFA (solvent A) and acetonitrile/0.1%
TFA (solvent B) or water/0.1% TFA (solvent A) and 80% acetoni-
trile/0.085% TFA, respectively, were used in the HPLC systems.
Fractions that showed an absorbance at 220 and 260 nm were
presumed to contain cross-linked peptide–RNA heteroconjugates
and thus subjected to further analysis by MALDI MS.
Mass spectrometry
MALDI-ToF measurements were performed with a Voyager DE-
STR instrument (Applied Biosystems) equipped with a pulsed
nitrogen laser (20 Hz, 337 nm) and with a Reflex IV instrument
(Bruker Daltonics) equipped with a pulsed nitrogen laser (5 Hz,
337 nm). For the Voyager DE-STR, the following conditions were
used: acceleration voltage 20 kV, grid voltage 92% (linear)/64%
(reflectron)/65% (PSD), and delay time 350 ns (linear)/250 ns
(reflectron)/100 ns (PSD). A total of 300 laser shots were summed
for each spectrum or PSD segment. For the Reflex IV, the accel-
eration voltage was 20 kV for the IS1 and 16.9 kV for the IS2, and
the delay time was 400 ns. A total of 300 laser shots (5 Hz, 337 nm)
were summed. PSD spectra were recorded with an acceleration
voltage of 25 kV (IS1) and 20.2 kV (IS2). The delay time was 200
ns, and a total of 210 laser shots were summed for each PSD
segment. The PSD spectrum in Figure 7A was recorded on an
Ultraflex ToF/ToF I instrument with PAN upgrade (Bruker Dal-
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tonics) equipped with a pulsed nitrogen laser (20 Hz, 337 nm).
The following PSD conditions were used: acceleration voltage 8.0
kV for IS1, 7.1 kV for IS2, reflector voltage 29 kV for R1, 14.5 kV
for R2, LIFT voltage 19 kV for LIFT1, 2.0 kV for LIFT2, and a total
of 1500 shots were summed.
For the measurements on the Voyager DE-STR, 0.5 mL of sample
was mixed on a stainless steel sample plate with the same volume of
CHCA (5 mg/mL in 50%ACN/0.1% TFA), DHB (10 mg/mL in 50%
ACN/0.1% TFA), or THAP (10 mg/mL in 50% ACN/0.5% TFA)
matrix solution. The preparation was allowed to dry at room tem-
perature and subjected toMS. For theMALDI-ToFmeasurements on
the Reflex IV, 0.5mL of the sample wasmixed on a Bruker Anchor600
or Anchor400 sample plate with the same volume of DHB (10mg/mL
in 50%ACN or water, respectively) solution. The preparation was air
dried as before and subjected to MS. Close external calibration with
peptide standards was performed on all instruments.
Database search and computational analysis of
peptide–RNA oligonucleotide cross-links
To calculate all theoretically possible combinations ofRNAandpeptide
fragments that match the experimentally determined mass of a cross-
linked peptide–RNA oligonucleotide, an exhaustive search algorithm
over all possible specific and unspecific fragments of given protein and
RNA sequences in the database was implemented within the Visual
Fortran environment (Hewlett-Packard). The algorithm allows the
following user-defined settings to specify and constrain the search: (1)
mass deviation, (2) the endoproteinases used, (3) the endonucleases
used, (4) the maximum number of missed cleavages on protein and
RNA sequences, (5) sequence tags of the putative cross-linked peptide
andRNAmoiety, and (6)UV-cross-linkable amino acids (C, F,H,K, L,
M, W, Y) based on Saito et al. (1983 a,b), Saito and Sugiyama (1990),
Williams andKonigsberg (1991), andMeisenheimer et al. (1996, 2000).
The two latter constraints greatly reduce the list of theoretically possible
cross-links in cases where there are ambiguous results. Furthermore,
the algorithm also takes into account unspecific cleavages and strand
breaks at theNandC terminiof theprotein and the 50 and30 endsof the
RNA. Therefore, the output list contains, at most, 16 subgroups of
putatively matching cross-links, among which specific cleavage of the
protein and RNA moieties has the highest priority.
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